Spartanburg Regional Healthcare System is one of South Carolina's largest healthcare systems. SRHS draws patients primarily from the areas of Spartanburg, Cherokee, Union and Greenville counties, located in the Piedmont region of South Carolina, and Rutherford and Polk counties, located in western North Carolina.

During the past decade, Spartanburg Medical Center conducted 166 clinical trials. In the 10-year time frame, 166 clinical trials started and 131 clinical trials were completed, i.e. on average, 78.9% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 69 clinical trials were completed. i.e. 125.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spartanburg Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 109 trials, followed by "SWOG Cancer Research Network" with 26 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SCRI Development Innovations, LLC" with 20 trials sponsored and "NRG Oncology" with 20 trials sponsored. Other sponsors include 125 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spartanburg Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 112 trials as a collaborator, "NRG Oncology" with 37 trials as a collaborator, "Genentech, Inc." with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator and "Cancer and Leukemia Group B" with 7 trials as a collaborator. Other collaborators include 123 different institutions and companies that were collaborators in the rest 86 trials.

According to Clinical.Site data, the most researched conditions in "Spartanburg Medical Center" are "Breast Cancer" (15 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Prostate Cancer" (9 trials), "Invasive Breast Carcinoma" (8 trials) and "Recurrent Breast Carcinoma" (8 trials). Many other conditions were trialed in "Spartanburg Medical Center" in a lesser frequency.

Most popular intervention types in "Spartanburg Medical Center" are "Drug" (220 trials), "Other" (166 trials), "Biological" (82 trials), "Radiation" (63 trials) and "Procedure" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "Quality-of-Life Assessment" (64 trials), "Questionnaire Administration" (44 trials), "Paclitaxel" (31 trials) and "Carboplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Spartanburg Medical Center" are 243 trials for "All" genders, 61 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Spartanburg Medical Center". undefined are not yet recruiting, 50 are recruiting, 120 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 118 completed trials in Spartanburg Medical Center, 4 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Spartanburg Medical Center, 15 "Phase 1" clinical trials were conducted, 121 "Phase 2" clinical trials and 150 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 29 trials that are defined as “Not Applicable".

Spartanburg Medical Center has several departments that took part in Clinical trials: "Cancer Centers of the Carolinas - Spartanburg" - 40 trials